Short Topics

The short topics below are thirty minutes or less, and provided as an educational opportunity and resource for laboratory professionals. Our Spotlight series focuses on test utilization, new tests, and testing technologies topics.

*Please note: Our short topics do not provide continuing education credits.

Spotlight on Testing:
Vaginitis Testing by TMA by Salika M. Shakir, PhD, (DABMM)
Spotlight on Testing Technology:
HIV Testing by NGS by David R. Hillyard, MD
Spotlight on Test Utilization:
Advancements in Biomarker Testing—Evolution of Immunotherapy Testing by Larry Meysing
Spotlight on Test Utilization:
Advancements in Biomarker Testing—TRK and NTRK Testing by Larry Meysing
Spotlight on Testing:
The Promise and Limitations of COVID-19 Antibody Testing — What We Know So Far by Julio C. Delgado, MD, MS, and Brian R. Jackson, MD, MS
Spotlight on Testing:
Phosphatidylethanol — A Long-term Biomarker for Alcohol Exposure by Kamisha L. Johnson-Davis, PhD, DABCC (CC,TC), FAACC
Spotlight on Testing Technology:
NGS-based Metagenomics Testing for the Diagnosis of Infectious Diseases by Robert Schlaberg, MD, Dr Med, MPH
Spotlight on Testing:
Imatinib - Therapeutic Drug Monitoring by Gwendolyn A. McMillin, PhD
Spotlight on Testing Technology:
Bioinformatics Analytics in Genetic Testing by Elaine Gee, PhD
Spotlight on Testing:
Umbilical Cord Collection by Various Authors
Spotlight on Testing:
Hepatitis C Virus NS5A Drug Resistance by Sequencing by David R. Hillyard, MD
Spotlight on Testing:
Essential Fatty Acids Profile Testing by Tatiana Yuzyuk, PhD
Spotlight on Testing:
Therapeutic Drug Monitoring (TDM) of Thiopurine Drugs by Kamisha Johnson-Davis, PhD, DABCC
Spotlight on Testing:
Metagenomics for Universal Pathogen Detection by Robert Schlaberg, MD, Dr Med, MPH
Spotlight on Testing:
Circulating Cell Free Tumor DNA and EGFR T790m Testing by Mary Bronner, MD
Spotlight on Testing:
Laboratory Testing for Evaluation of Renal Calculi and Assessment of Stone Risk by Elizabeth L. Frank, PhD
Spotlight on Test Utilization:
Prenatal Diagnosis in the Genomic Microarray Era by Allen N. Lamb, PhD, FACMG
Spotlight on Testing:
Phospholipase A2 Receptor (PLA2R) IgG Antibody: A Marker for Primary Membranous Nephropathy by Anne E. Tebo, PhD
Spotlight on Testing:
Genetic Testing for Hereditary Breast and Ovarian Cancer Syndrome by Hunter Best, PhD
Spotlight on Testing:
Importance of Testing for Lysosomal Acid Lipase Deficiency in Patients with Liver Dysfunction and Dyslipidemia by Irene DeBiase, MD, PhD
Spotlight on Testing:
High-Resolution HLA Genotyping by Next-Generation Sequencing by Julio Delgado, MD, MS
Spotlight on Testing:
Test-Guided Management of Treatment Failure to TNF-alpha Antagonists by Julio Delgado, MD, MS
Spotlight on Testing:
Non-Invasive Markers for Assessing Liver Fibrosis by Patricia R. Slev, PhD
Spotlight on Testing:
Molecular Diagnostics of Gastrointestinal Parasites by Marc Roger Couturier, PhD, D(ABMM)
Spotlight on Testing:
Biochemical Testing for Pheochromocytoma by Elizabeth L. Frank, PhD, and Sarah A. Hackenmueller, PhD, DABCC
Spotlight on Testing:
Heparin-induced Thrombocytopenia and the Serotonin Release Assay by Kristi J. Smock, MD
Spotlight on Testing Technologies:
An Overview of Time of Flight Mass Spectrometry by Frederick Strathmann, PhD, DABCC (CC,TC)
Spotlight on Testing:
Utility of Genetic Testing for Mutations in the EIF2AK4 Gene in the Diagnosis of Pulmonary Capillary Hemangiomatosis and Pulmonary Veno-occlusive Disease by Hunter Best, PhD
Spotlight on Test Utilization:
Fetal Lung Maturity Testing by David G. Grenache, PhD
Spotlight on Test Utilization:
New and Old Strategies for Detecting In Utero Drug Exposure by Frederick Strathmann, PhD, DABCC (CC,TC)
Spotlight on Test Utilization:
Direct Free Copper versus Calculated Free Copper in Wilson Disease Diagnosis and Monitoring by Frederick Strathmann, PhD, DABCC (CC,TC)
Spotlight on Test Utilization:
Quantitation, Confirmation and Compliance Determination using Urine Drug Test Results by Frederick Strathmann, PhD, DABCC (CC,TC)
Spotlight on Test Utilization:
Genomic MicroArray by Sarah South, PhD
Spotlight on Test Utilization:
Clinical Utility of Testing for Myelin Basic Protein by David G. Grenache, PhD
Spotlight on Test Utilization:
Cytogenetic Testing for Myeloproliferative Neoplasms by Sarah South, PhD
Spotlight on Testing Technology:
Digital Imaging by Mohamed E. Salama, MD
Spotlight on Test Utilization:
STD Screening in MSM - Importance of Testing Extra-Genital Sites by Robert Schlaberg, MD, MPH
Spotlight on Test Utilization:
H. pylori Diagnostics by Marc Roger Couturier, PhD
Spotlight on Test Utilization:
Choosing Wisely Campaign by Ronald L. Weiss, MD, MBA
Spotlight on Test Utilization:
Clinical Performance Comparison of FDA-Cleared HPV Tests by Robert Schlaberg, MD, MPH
Spotlight on Test Utilization:
Clinical Performance Comparison of FDA-Cleared HPV Tests by Robert Schlaberg, MD, MPH
Spotlight on Testing:
Leflunomide by Kamisha Johnson-Davis, PhD
Spotlight on Test Utilization:
Arsenic Fractionation by Frederick Strathmann, PhD, DABCC (CC,TC)
Spotlight on Testing:
Warfarin Pharmacogenetics by Gwendolyn A. McMillin, PhD
Spotlight on Testing Technology:
Technologies Used for Drug Testing by Gwendolyn A. McMillin, PhD
Spotlight on Testing:
Drug Testing with Umbilical Cord Tissue by Gwendolyn A. McMillin, PhD
Test Utilization Discussions:
Should the Qualitative Serum Pregnancy Test Be Considered Obsolete? by David G. Grenache, PhD, and Larissa V. Furtado, MD
AACC 2019 Booth Presentation:
Defining the Downstream Impact of Laboratory Stewardship by Andrew Fletcher, MD, CPE
AACC 2019 Booth Presentation:
Harnessing the Power of Pharm/Lab Collaboration by Danielle Kauffman, PharmD, MBA
AACC 2019 Booth Presentation:
Back to Our Roots: The Healing Power of Ethical Business Strategies by Brian R. Jackson, MD, MS
AACC 2019 Booth Presentation:
The True Life Story of Automating a Hospital Laboratory by Jo D Fontenot, MS, MT(ASCP)
AACC 2017 Booth Presentation:
Advances in Viral Hepatitis Testing by Patricia R. Slev, PhD
AACC 2017 Booth Presentation:
Earning Customer Loyalty through Tough Love by Brian Jackson, MD, MS
AACC 2017 Booth Presentation:
Inflammatory Myopathies— A Laboratory Update on Autoantibody Testing by Anne E. Tebo, PhD
AACC 2017 Booth Presentation:
Inborn Errors of Metabolism— The Needle in the Haystack by Irene De Biase, MD, PhD, FACMG
AACC 2016 Booth Presentation:
Three Critical Success Factors to Fuel Lab UM Programs by Brian R. Jackson, MD, MS
AACC 2016 Booth Presentation:
All the Right Technology in All the Right Places: The Necessary Evolution of Urine Drug Testing by Frederick Strathmann, PhD
AACC 2016 Booth Presentation:
Utilization Management and Beyond: The Many Roles of Genetic Counselors in the Lab by Sara Brown, MS, LCGC
AACC 2016 Booth Presentation:
Molecular Detection of Gastrointestinal Pathogens by Marc Roger Couturier, PhD, D(ABMM)
AACC 2015 Booth Presentation:
If Baby Could Talk: Laboratory Detection of Prenatal Drug Exposure by Gwendolyn A. McMillin, PhD
AACC 2015 Booth Presentation:
An Interferent No More: Measuring Thyroglobulin in the Presence of Anti-Thyroglobulin Autoantibodies by Joely A. Straseski, PhD, MS, MT(ASCP), DABCC
AACC 2015 Booth Presentation:
Cell-free DNA Tests for Non-invasive Prenatal Aneuploidy Screening by David G. Grenache, PhD
AACC 2015 Booth Presentation:
Non-Invasive Assessment of Liver Fibrosis by Patricia R. Slev, PhD
Test Utilization Study:
Vitamin D Utilization Management Study: An Overview of Results by Robert Schmidt, MD, PhD, MBA, and Joely A. Straseski, PhD, MS, MT(ASCP), DABCC
PainWeek 2014 Booth Presentation:
Understanding the Technology: Is Mass Spectrometry really better or are immunoassays just fine? by Frederick Strathmann, PhD, DABCC (CC,TC)
PainWeek 2014 Booth Presentation:
Making Sense of the Patterns: Is it Oxycodone or not... and other compliance interpretation questions by Frederick Strathmann, PhD, DABCC (CC,TC)
AACC 2014 Booth Presentation:
How to Estimate the Impact of Changing Laboratory Methods by Robert Schmidt, MD, PhD, MBA
AACC 2014 Booth Presentation:
Extreme Makeover: Lab Edition by Brian R. Jackson, MD, MS
AACC 2014 Booth Presentation:
Risk Stratification in Heart Failure - The Role of Emerging Biomarkers by David G. Grenache, PhD
AACC 2014 Booth Presentation:
How Automation is Necessary to Achieve Six-Sigma Quality by Charles D. Hawker, PhD, MBA, FACB
Painweek 2013 Booth Presentation:
The Clinical Utility of Pharmacogenetic Testing in Pain Management by Gwendolyn McMillin, PhD, DABCC(CC,TC)
Painweek 2013 Booth Presentation:
What’s in a number? Can Quantitative Drug Testing Results Be Used to Delineate Partial vs. Full Dose Compliance by Gwendolyn McMillin, PhD, DABCC(CC,TC)
AACC 2013 Booth Presentation:
A Hippocratic Oath for the Diagnostics Industry by Brian R. Jackson, MD, MS
AACC 2013 Booth Presentation:
Children Aren't Small Adults! (and Other Pediatric Reference Interval Challenges) by Joely A. Straseski, PhD, MS, MT(ASCP), DABCC
AACC 2013 Booth Presentation:
Why Labs Request Clinical Information: Examining the Impact on Patient Care by Elaine Lyon, PhD
AACC 2013 Booth Presentation:
What’s in a number? Can Quantitative Drug Testing Results Be Used to Delineate Partial vs. Full Dose Compliance by Gwendolyn McMillin, PhD, DABCC(CC,TC)
Test Utilization:
Appropriate Utilization of Drug Tests for Pain Management Patients by Gwendolyn A. McMillin, PhD
Painweek 2012 Booth Presentation:
Strategies to Detect and Prevent Adulteration and Substitution in Urine Drug Testing by Kamisha Johnson-Davis, PhD, DABCC
Painweek 2012 Booth Presentation:
Managing Costs Associated with Chronic Pain by Early Detection of Nonadherence & Cost-conscious Urine Drug Monitoring by Gordon Nelson, C(ASCP), NRCC-TC
AACC 2012 Booth Presentation:
Utility of Anti-Müllerian Hormone as a Marker of Ovarian Reserve by Joely A. Straseski, PhD, MS, MT(ASCP), DABCC
AACC 2012 Booth Presentation:
Roles of the Clinical Laboratory in Pain Management by Gwendolyn A. McMillin, PhD
AACC 2012 Booth Presentation:
Analysis Approaches for the Clinical Exome by Elaine Lyon, PhD
AACC 2012 Booth Presentation:
Gastrointestinal Polyposes and Cancer Syndromes: Pathologic and Genetic Diagnosis by Mary Bronner, MD
APS 2012 Booth Presentation:
Cost-effective Utilization of Urine Drug Testing for Chronic Pain Management Patients by Gordon Nelson, C(ASCP), NRCC-TC
APS 2012 Booth Presentation:
A Novel Approach to Drug Screening with Blood by Gwendolyn A. McMillin, PhD
APS 2012 Booth Presentation:
Patterns of Opioid Metabolites in Urine - The Buprenorphine Story by Gwendolyn A. McMillin, PhD
Test Utilization:
Improving ordering practices for the diagnosis of Helicobacter pylori by Marc Roger Couturier, PhD
Test Utilization:
The Changing Landscape of Fetal Lung Maturity Testing by David G. Grenache, PhD
Test Utilization:
Inherited Thrombophilia Testing: Pros and Cons by George M. Rodgers III, MD, PhD, and Kristi J. Smock, MD
Point of Care:
Leading the Way by Jo D Fontenot, MS, MT(ASCP)
Rapid On Site Evaluation (R.O.S.E.) of EUS FNA Samples
by Benjamin L. Witt, MD and Douglas G. Adler MD, FACG, AGAF, FASGE
Evidence Based Diagnostics
by Brian R. Jackson, MD, MS and Robert Schmidt, MD, PhD, MBA
Interpreting Toxicology Test Results
by Maggie Hopkins, MD, MBA and Gwendolyn A. McMillin, PhD
Theraputic Drug Monitoring
by Maggie Hopkins, MD, MBA and Kamisha Johnson-Davis, PhD
Analytical Methods in Toxicology Testing
by Maggie Hopkins, MD, MBA and Frederick G. Strathmann, PhD, DABCC (CC, TC)
LabMind - An Interview With Dennis Strenk:
The People of Pathology by Brian R. Jackson, MD, MS
LabMind - An Interview With Dr. Karen Heichman:
Person-Centric Innovation to Improve Diagnostic Testing in Global Health by Brian R. Jackson, MD, MS
LabMind - An Interview With Andy Theurer:
How Do You Continue Building a Great Company? by Brian R. Jackson, MD, MS
LabMind - An Interview With Dr. Sherrie Perkins:
The Cultural Legacy of a CEO by Brian R. Jackson, MD, MS
LabMind - An Interview With Dr. Joseph Anderson:
Where is Pathology Heading? by Brian R. Jackson, MD, MS
LabMind - An Interview With Heidi Wallis:
A Patient Perspective on Diagnostic Testing by Brian R. Jackson, MD, MS
LabMind - An Interview With Dr. Ryan Metcalf:
Personalizing Transfusion Medicine by Brian R. Jackson, MD, MS
LabMind - An Interview With Paul Epner:
Improving Diagnostics in Medicine by Brian R. Jackson, MD, MS
LabMind - An Interview With Drs. Marzia Pasquali and Nicola Longo:
A Distinctive Diagnostic Partnership in Pediatrics by Brian R. Jackson, MD, MS
LabMind - An Interview With Dr. Kim Hanson:
The Pandemic Year in Review by Brian R. Jackson, MD, MS
LabMind - An Interview With Drs. Nadine Fydryszewski and Brandy Gunsolus:
Why Every Health System Needs Doctors of Clinical Laboratory Science (DCLSs) by Brian R. Jackson, MD, MS
LabMind - An Interview With Dr. Jim Crawford, Mike Eller, and Chris Zavala:
Bringing Phlebotomy Services to the Home and Workplace with LabFly by Brian R. Jackson, MD, MS
LabMind - An Interview With Rick Panning:
How Laboratories Can Reduce the Total Cost of Care by Brian R. Jackson, MD, MS
LabMind - An Interview With Maddie Josephs:
Finding Meaning Through a Career in Clinical Laboratory Science by Brian R. Jackson, MD, MS
LabMind - An Interview With Dr. Jon Genzen:
The Lab Must Go On, Despite the Disruption of a Pandemic by Brian R. Jackson, MD, MS
LabMind - An Interview With Diana Wilkins, Takara Blamires, and Misty Smith:
Recruiting the Next Generation of Clinical Laboratory Scientists by Brian R. Jackson, MD, MS
LabMind - An Interview With Dr. Ryan Metcalf:
Convalescent Plasma Therapy for COVID-19 by Brian R. Jackson, MD, MS
LabMind - An Interview With Dr. Kathryn Gibson:
Protecting ARUP’s Workforce Members and Their Families During the Pandemic by Brian R. Jackson, MD, MS
LabMind - An Interview With Dr. Peter Weir:
Primary Care the Way It Was Meant to Be at the ARUP Family Health Clinic by Brian R. Jackson, MD, MS
LabMind - An Interview With ARUP's Supply Chain Management Team:
How the COVID-19 Pandemic Has Upended Laboratory Purchasing by Brian R. Jackson, MD, MS
LabMind - An Interview With Dr. David Grenache:
Lab-Developed vs FDA-Regulated Tests — Separating Fact from Fiction by Brian R. Jackson, MD, MS
LabMind - An Interview With Dr. Julio Delgado:
Personal Insights on Leading a Laboratory During a Pandemic by Brian R. Jackson, MD, MS
LabMind - An Interview With Dr. Tracy Frech:
Patient- and Science-Centered Support for Patients with Autoimmune Disease during the COVID-19 Pandemic by Brian R. Jackson, MD, MS
LabMind - An Interview With Dr. David Hillyard:
Delving into the Sensitivity of SARS-CoV-2 Diagnostic Testing by Brian R. Jackson, MD, MS
LabMind - An Interview With Pam Banning:
Laying the Groundwork for Data-Driven Health Care by Brian R. Jackson, MD, MS
LabMind - An Interview With Drs. Kristi Smock and Karen Moser:
Making Sense of Thrombotic Complications in COVID-19 by Brian R. Jackson, MD, MS
LabMind - An Interview With Dr. Robert Schlaberg:
How Unbiased Sequencing Technology Is Improving Infectious Disease Diagnostics, from Routine Clinical Care to New Pandemics by Brian R. Jackson, MD, MS
LabMind - An Interview With Dr. Marc Couturier:
Improving Collaboration Between Clinical and Public Health Labs by Brian R. Jackson, MD, MS
LabMind - An Interview With Sam Marsden:
A Peek Behind the Curtain of Data Reporting for COVID-19 and Other Public Health Events by Brian R. Jackson, MD, MS
LabMind - An Interview With Dr. Tracy George:
How an Academic Clinical Laboratory Has Become a Collaboration Hub to Accelerate COVID-19 Scientific Discovery by Brian R. Jackson, MD, MS
LabMind - An Interview With Drs. Patricia Slev and Jenna Rychert:
Antibody Testing for COVID-19 by Brian R. Jackson, MD, MS
LabMind - An Interview With Dr. Hardeep Singh:
Focusing on the Fundamentals Prevents Diagnostic Errors by Brian R. Jackson, MD, MS
LabMind - An Interview With Dr. Mark Graber (Part I):
Preventing Diagnostic Errors by Brian R. Jackson, MD, MS
LabMind - An Interview With Dr. Mark Graber (Part II):
Preventing Diagnostic Errors by Brian R. Jackson, MD, MS
LabMind - An Interview With Elissa Passiment:
The History and Future of Medical Laboratory Scientists by Brian R. Jackson, MD, MS
LabMind - An Interview With Dr. Ila Singh:
The TRUU-Lab Initiative to Improve Laboratory Test Names by Brian R. Jackson, MD, MS
LabMind - An Interview With Dr. Ronald Weiss:
Ethics-Centered Leadership within the Healthcare Industry by Brian R. Jackson, MD, MS
LabMind - An Interview With Dr. Ana Stankovic:
Practicing Laboratory Science in the IVD Industry by Brian R. Jackson, MD, MS
LabMind - An Interview With Dr. Elaine Lyon:
How Genetic Testing is Different by Brian R. Jackson, MD, MS
LabMind - An Interview With Dr. Mike Laposata:
Overcoming Barriers as A Diagnostic Management Team by Brian R. Jackson, MD, MS
LabMind - An Interview With Dr. Harry Hill:
The Value of Academic Medicine and Academic Clinical Laboratories by Brian R. Jackson, MD, MS
LabMind - An Interview With Dr. Rita Horvath:
Applying Evidence-Based Medicine to the Laboratory by Brian R. Jackson, MD, MS
LabMind - An Interview With Dr. Carl Wittwer:
The Truth, Not the Myth, of Inventing by Brian R. Jackson, MD, MS
LabMind - An Interview With Khosrow Shotorbani:
Moving Clinical Laboratories Beyond Simply Performing Tests by Brian R. Jackson, MD, MS
LabMind - An Interview With Dr. Michael Astion:
Serial Academic Entrepreneur by Brian R. Jackson, MD, MS
LabMind - An Interview With Dr. Carl Kjeldsberg (Part I):
Founding and the Early Shaping of ARUP by Brian R. Jackson, MD, MS
LabMind - An Interview With Dr. Carl Kjeldsberg (Part II):
Scaling ARUP into a Mature Company by Brian R. Jackson, MD, MS
LabMind - An Interview With Dr. Andrew Fletcher:
His Career Path and Expanding the Role of Pathologists by Brian R. Jackson, MD, MS